Weekly (rather than biweekly) dosing of Humira is generally used only for monotherapy without methotrexate, so the Humira dosing in the Tofacitinib study you’re referring to was normal.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”